Finding Long-Term Control Over Atopic Dermatitis Despite Persistent Flare-Ups
Home Doctors Ask a Doctor Online Success Stories Finding Long-Term Control Over Atopic Dermatitis Despite Persistent Flare-Ups

Finding Long-Term Control Over Atopic Dermatitis Despite Persistent Flare-Ups

Living with atopic dermatitis can be physically exhausting and emotionally overwhelming, especially when flare-ups continue despite following treatment. For one young adult, eczema had been a lifelong challenge. The condition mainly affected the folds of the skin and neck, causing persistent itching, inflammation, and discomfort that often interfered with daily life.

After years of using topical steroids and Tacrolimus ointment, the patient recently started Dupilumab injections, hoping to finally gain control over the disease. While the skin showed noticeable improvement, flare-ups still occurred, particularly during periods of emotional stress. Blood investigations also revealed elevated eosinophil counts and very high Immunoglobulin E (IgE) levels, leading to concerns that the treatment might not be working effectively. Questions about whether topical steroids should be stopped, whether food restrictions should continue, and how to prevent future flare-ups left the patient feeling uncertain.

Seeking expert guidance, the patient consulted iCliniq.

The consultation provided reassurance and a clear understanding of the recovery process. The iCliniq specialist explained that Dupilumab is one of the most effective treatments for moderate-to-severe atopic dermatitis, but its full benefits are usually seen after three to six months of consistent treatment. Experiencing flare-ups during the early months, particularly those triggered by stress or environmental allergens, is not uncommon and does not indicate treatment failure.

The doctor also clarified that high IgE and eosinophil levels are frequently seen in patients with severe atopic dermatitis and may remain elevated even after starting biologic therapy. Rather than discontinuing topical medications abruptly, the patient was advised to continue using topical corticosteroids during flare-ups and gradually taper them as the skin improved. For sensitive areas such as the face and neck, Tacrolimus ointment remained a suitable treatment option. Regular use of ceramide-based moisturizers was recommended to strengthen the skin barrier and reduce future flare-ups.

Another important concern involved food restrictions. The specialist explained that unless IgE-mediated food allergies had been confirmed, eliminating multiple foods unnecessarily was not recommended. Instead, foods could be reintroduced gradually under medical supervision. The patient also learned that stress management, adequate sleep, avoiding harsh soaps and detergents, wearing breathable clothing, and maintaining regular moisturization were equally important components of long-term eczema control.

Armed with a better understanding of the condition, the patient continued treatment with confidence instead of losing hope after the initial flare-ups. Over time, the skin became more stable, itching reduced significantly, and flare-ups became less frequent and easier to control.

This journey highlights that managing chronic atopic dermatitis requires patience, consistency, and expert guidance. Through iCliniq's evidence-based recommendations and personalized care, the patient learned that successful treatment is not about eliminating every flare immediately—it is about understanding the disease, following the right treatment plan, and achieving lasting control over time.

Doctors Online

2029

ask-doctor-img Ask a Doctor Online



What our Users Say!

Start your chat with a doctor for medical advice now.